Malnutrition among pregnant women increases in 12 countries at risk

Published Date: 08 Mar 2023

Malnutrition among pregnant and breastfeeding women has increased by 25% in the past two years in 12 countries affected by rising food prices caused by the war in Ukraine, according to United Nations news.

Read Full News

Latest News



Todays Updates


5 Rheumatology Headlines You Missed in December 2025 Victoria Johnson


This rheumatology month in review emphasizes new data and impactful approvals.

Q4 2025 Recap: Rheumatology News and Updates Victoria Johnson


The Q4 recap for rheumatology spotlights regulatory and clinical advances across rheumatic diseases.

Exploring Depressive Symptoms in Low-IQ Youth with Refractory Epilepsy Janelle L Wagner, PhD, Shannon Brothers, PhD, Cortney Wolfe-Christensen, PhD, Louie Pasculli


A trio of clinician authors provided insights on a recently published paper assessing youths with refractory epilepsy and ways to combat depressive symptoms.

FDA Approves Subcutaneous Copper Histidinate as First Treatment for Pediatric Menkes Disease Isabella Ciccone, MPH


The FDA approved Sentynl Therapeutics’ copper histidinate for the treatment of pediatric Menkes disease, a rare genetic neurodegenerative disorder, following an earlier complete response letter.

Rituximab Displays Long-Term Effectiveness for Relapsing MS Louie Pasculli


Annette Lenger-Gould, MD, PhD, lead for clinical and translational neuroscience at Kaiser Permanente, discusses findings and significance from a recently published trial assessing rituximab in patients with relapsing multiple sclerosis.

NeuroVoices: Nicholas Ashton, PhD, on Advances and Challenges in Alzheimer Disease Biomarkers Nicholas Ashton, PhD, Isabella Ciccone, MPH


The senior director of the Fluid Biomarker Program at Banner Health highlighted the evolving role of blood and fluid biomarkers in Alzheimer disease research and clinical practice.

High-Dose Nusinersen Gains European Commission Approval for Spinal Muscular Atrophy Louie Pasculli


The European Commission approved Biogen’s high-dose nusinersen regimen for 5q SMA, supported by DEVOTE trial data showing significantly improved motor function with a safety profile consistent with the standard-dose regimen.

Todays Updates


5 Rheumatology Headlines You Missed in December 2025 Victoria Johnson


This rheumatology month in review emphasizes new data and impactful approvals.

Q4 2025 Recap: Rheumatology News and Updates Victoria Johnson


The Q4 recap for rheumatology spotlights regulatory and clinical advances across rheumatic diseases.

Exploring Depressive Symptoms in Low-IQ Youth with Refractory Epilepsy Janelle L Wagner, PhD, Shannon Brothers, PhD, Cortney Wolfe-Christensen, PhD, Louie Pasculli


A trio of clinician authors provided insights on a recently published paper assessing youths with refractory epilepsy and ways to combat depressive symptoms.

FDA Approves Subcutaneous Copper Histidinate as First Treatment for Pediatric Menkes Disease Isabella Ciccone, MPH


The FDA approved Sentynl Therapeutics’ copper histidinate for the treatment of pediatric Menkes disease, a rare genetic neurodegenerative disorder, following an earlier complete response letter.

Rituximab Displays Long-Term Effectiveness for Relapsing MS Louie Pasculli


Annette Lenger-Gould, MD, PhD, lead for clinical and translational neuroscience at Kaiser Permanente, discusses findings and significance from a recently published trial assessing rituximab in patients with relapsing multiple sclerosis.

NeuroVoices: Nicholas Ashton, PhD, on Advances and Challenges in Alzheimer Disease Biomarkers Nicholas Ashton, PhD, Isabella Ciccone, MPH


The senior director of the Fluid Biomarker Program at Banner Health highlighted the evolving role of blood and fluid biomarkers in Alzheimer disease research and clinical practice.

High-Dose Nusinersen Gains European Commission Approval for Spinal Muscular Atrophy Louie Pasculli


The European Commission approved Biogen’s high-dose nusinersen regimen for 5q SMA, supported by DEVOTE trial data showing significantly improved motor function with a safety profile consistent with the standard-dose regimen.

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Advanced breast cancer patients living longer thanks to improvements in treatment and care

2.

Decrease seen in in situ breast cancer since 2009

3.

Appropriate New Monoclonal for Immunocompromised Individuals to Prevent COVID-19.

4.

AI is useful in low-resource areas for triaging breast masses.

5.

When performed by skilled surgeons, robotic surgery for pancreatic tumors is safe and feasible.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot